The Journal of Urology
Volume 179, Issue 2 , Pages 485-490 , February 2008

Prevention of Recurrence With Epirubicin and Lactobacillus Casei After Transurethral Resection of Bladder Cancer

  • Seiji Naito

      Affiliations

    • Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • Corresponding Author InformationCorrespondence: Department of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan (telephone: +81-92-642-5601; FAX: +81-92-642-5618).
    • ,
  • Hirofumi Koga

      Affiliations

    • Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Akito Yamaguchi

      Affiliations

    • Department of Urology, Harasanshin General Hospital, Fukuoka, Japan
    • ,
  • Naohiro Fujimoto

      Affiliations

    • Department of Urology, University of Occupational and Environmental Health, Miyazaki, Japan
    • ,
  • Yoshihiro Hasui

      Affiliations

    • Department of Urology, Kitakyushu and Miyazaki Medical College, Miyazaki, Japan
    • ,
  • Hiroshi Kuramoto

      Affiliations

    • Department of Urology, Moji Rousai Hospital, Miyazaki, Japan
    • ,
  • Atsushi Iguchi

      Affiliations

    • Department of Urology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
    • ,
  • Naoko Kinukawa

      Affiliations

    • Department of Medical Information on Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Kyushu University Urological Oncology Group

Received 2 May 2007

References 

  1. Jone JS, Campbell SC. Non-muscle-invasive bladder cancer (Ta, T1, and CIS). In:  Wein AJ,  Kavoussi LR,  Novick AC,  Partin AW,  Peters CA editor. Campbell-Walsh Urology. 9th ed.. Philadelphia: WB Saunders Co; 2007;p. 2447–2467
  2. Hinotsu S, Akaza H, Ohashi Y, Kotake T. Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function. Cancer. 1999;86:1818
  3. Nilsson S, Ragnhammar P, Glimelius B, Nygren P. Swedish Council of Technology Assessment in Health Care: a systematic overview of Chemotherapy effects in urothelial bladder cancer (SBU-group). Acta Oncol. 2001;40:371
  4. Lamm DL, Blumenstein BA, Crawford ED, Montie JE, Scardino P, Grossman HB, et al. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder. N Engl J Med. 1991;325:1205
  5. Kato I, Endo K, Yokokura T. Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice. Int J Immunopharmacol. 1994;16:29
  6. Takahashi T, Kushiro A, Nomoto K, Uchida K, Morotomi M, Yokokura T, et al. Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT-2. J Urol. 2001;166:2506
  7. Aso Y, Akazan H. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer (BLP Study Group). Urol Int. 1992;49:125
  8. Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial (The BLP Study Group). Eur Urol. 1995;27:104
  9. Holford TR. Life tables with concomitant information. Biometrics. 1976;32:587
  10. Ali-el-Dein B, Nabeeh A, el-Baz M, Shamaa S, Ashamallah A. Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional-cell bladder tumours: a prospective, randomized controlled study. Br J Urol. 1997;79:731
  11. Okamura K, Kinukawa T, Tsumura Y, Otani T, Itoh H, Kobayashi H, et al. A randomized study of short-versus long-term intravesical epirubicin instillation for superficial bladder cancer (Nagoya University Urological Oncology Group). Eur Urol. 1998;33:285
  12. Koga H, Kuroiwa K, Yamaguchi A, Osada Y, Tsuneyoshi M, Naito S, et al. A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder. J Urol. 2004;171:153
  13. Fuller R. Probiotics in man and animals. J Appl Bacteriol. 1989;66:365
  14. Lee YK, Nomoto K, Salminen S, Gorbach SL. Probiotic microorganisms. In:  Lee YK,  Nomoto K,  Salminen S,  Gorbach SL editor. Handbook of Probiotics. New York: John Wiley and Sons; 1999;p. 4–17
  15. Ohashi Y, Nakai S, Tsukamoto T, Masumori N, Akaza H, Miyanaga N, et al. Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol Int. 2002;68:273
  16. Hayatsu H, Hayatsu T. Suppressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human. Cancer Lett. 1993;73:173
  17. Nagao F, Nakayama M, Muto T, Okumura K. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci Biotechnol Biochem. 2000;64:2706

 Study received local institutional review board approval.

 For another article on a related topic see page 743.

PII: S0022-5347(07)02531-1

doi: 10.1016/j.juro.2007.09.031

The Journal of Urology
Volume 179, Issue 2 , Pages 485-490 , February 2008

Article Tools

* Image Usage & Resolution